Analyzing Fetal Outcomes Variability in Women with Short Inter-Pregnancy Intervals: A Cross-Sectional Study : Analyzing Fetal Outcomes Variability in Women

Ayesha Ismail; Syeda Seher Iqbal

doi:10.54393/pbmj.v6i12.1004

Authors

Ayesha Ismail Department of Obstetrics and Gynaecology, Ayub Teaching Hospital, Abbottabad, Pakistan
Syeda Seher Iqbal Department of Obstetrics and Gynaecology, Ayub Teaching Hospital, Abbottabad, Pakistan

DOI:

https://doi.org/10.54393/pbmj.v6i12.1004

Keywords:

Inter-Pregnancy Interval, Birth Weight, Early Neonatal Death, Premature Membrane

Abstract

The optimal interpregnancy interval (IPI) of 18-23 months is crucial for a mother's health, preventing adverse perinatal outcomes. Short IPI, particularly in females with a history of Cesarean section opting for vaginal birth, is associated with a 2 to 3 times increased risk of uterine rupture and other major morbidities. Objective: To assess the frequency of various fetal outcomes in women with short inter-pregnancy intervals. Methods: The study employed a Non-probability Consecutive sampling technique over nine months, from September 28, 2020, to June 20, 2021, comprising 170 female subjects who met inclusion criteria and provided informed consent, parameters such as parity, gestational age, and details about previous births were investigated. Presenting complaints were recorded using data collection proforma. The assessments included a thorough physical examination, per abdomen evaluation based on gestational age, and vaginal examination. Results: Maternal age data were analyzed using SPSS version 21.0 categorized into four groups, with mean age of 30 ± 1.27. Gravidity status was divided into three categories: 77.65% were multigravida, 18.82% were grand multigravida, and 3.53% were great grand multigravida among patients. Notably, 32.35% of females experienced preterm premature rupture of membranes, 38.82% had neonates born preterm, 12.35% suffered early neonatal death, and 25.29% had newborns with less weight at birth. Conclusions: The research concluded that short IPI is a significant factor in adverse fetal outcomes, negatively impacting maternal and child well-being.

References

Ahrens K, Nelson H, Stidd R, Moskosky S, Hutcheon, J. Short interpregnancy intervals and adverse perinatal outcomes in high-resource settings: An updated systematic review. Paediatric Perinatal Epidemiology. 2019 Dec; 33(1): O25-O47. doi: 10.1111/ppe.12503. DOI: https://doi.org/10.1111/ppe.12503

American College of Obstetricians and Gynecologists; Society for Maternal-Fetal Medicine. Obstetric Care Consensus No. 8: Interpregnancy Care. Obstetrics Gynecology. 2019 Jan; 133(1): e51-e72. doi: 10.1097/AOG.0000000000003025. DOI: https://doi.org/10.1097/AOG.0000000000003025

Mahande MJ and Obure J. Effect of interpregnancy interval on adverse pregnancy outcomes in northern Tanzania: a registry-based retrospective cohort study. BMC Pregnancy and Childbirth. 2016 Dec; 16(1): 1-9. doi: 10.1186/s12884-016-0929-5. DOI: https://doi.org/10.1186/s12884-016-0929-5

Shree R and Caughey A, Chandrasekaran S. Short interpregnancy interval increases the risk of preterm premature rupture of membranes and early delivery. Journal of Maternal and Fetal Neonatal Medicine. 2018 Nov; 31(22): 3014-20. doi: 10.1080/14767058.2017.1362384. DOI: https://doi.org/10.1080/14767058.2017.1362384

McKinney D, House M, Chen A, Muglia L, DeFranco E. The influence of interpregnancy interval on infant mortality. American Journal of Obstetrics and Gynecology. 2017 Mar; 216(3): 316. e1-9. doi: 10.1016/j.ajog.2016.12.018. DOI: https://doi.org/10.1016/j.ajog.2016.12.018

Cain M, Salemi J, Tanner J, Kirby R, Salihu H, Louis J. Pregnancy as a window to future health: maternal placental syndromes and short-term cardiovascular outcomes. American Journal of Obstetrics and Gynecology. 2016 Oct; 215: 484. e1–14. doi: 10.1016/j.ajog.2016.05.047. DOI: https://doi.org/10.1016/j.ajog.2016.05.047

Schwandt H, Skinner J, Hebert L, Cobb L, Saad A, Odeku M. Inadequate birth spacing is perceived as riskier than all family planning methods, except sterilization and abortion, in a qualitative study among urban Nigerians. BMC Women’s Health. 2017 Dec; 11; 17(1): 80. doi: 10.1186/s12905-017-0439-2. DOI: https://doi.org/10.1186/s12905-017-0439-2

Hanley G, Hutcheon J, Kinniburgh B, Lee L. Interpregnancy interval and adverse pregnancy outcomes: an analysis of successive pregnancies. Obstetrics and Gynecology. 2017 Mar; 129: 408–15. doi: 10.1097/AOG.0000000000001891. DOI: https://doi.org/10.1097/AOG.0000000000001891

Morse J and Moos M. Reproductive life planning: raising the questions. Maternal Child Health Journal. 2018 Apr; 22: 439–44. doi: 10.1007/s10995-018-2516-z. DOI: https://doi.org/10.1007/s10995-018-2516-z

Curtis K, Tepper N, Jatlaoui T, Berry-Bibee E, Horton L, Zapata L. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recommendations and Reports. 2016 Jul; 65(RR-3): 1–104. doi: 10.15585/mmwr.rr6503a1. DOI: https://doi.org/10.15585/mmwr.rr6503a1

American College of Obstetricians and Gynecologists. Immediate postpartum long-acting reversible contraception. Committee Opinion Number 670. Obstetrics Gynecology. 2016; 128: e32-37. doi: 10.1097/AOG.0000000000001587. DOI: https://doi.org/10.1097/AOG.0000000000001587

Makins A and Cameron S. Post-pregnancy contraception. Best Practice and Research Clinical Obstetrics and Gynecology. 2020 Jul; S1521-6934(20); 30016-X.

Bhadra B, Burman S, Purandare C, Divakar H, Sequeira T, Bhardwaj A. The impact of using nurses to perform postpartum intrauterine device insertions in Kalyani Hospital, India. International Journal of Obstetrics and Gynecology. 2018 Sep; 143 Suppl 1: 33-7. doi: 10.1002/ijgo.12602. DOI: https://doi.org/10.1002/ijgo.12602

Muganyizi P, Kimario G, Ponsian P, Howard K, Sethi M, Makins A. Clinical outcomes of postpartum intrauterine devices inserted by midwives in Tanzania. International Journal of Obstetrics and Gynecology. 2018 Sep; 143(1): 38-42. doi: 10.1002/ijgo.12603. DOI: https://doi.org/10.1002/ijgo.12603

Makins A, Taghinejadi N, Sethi M. FIGO postpartum intrauterine device initiative: Complication rates across six countries. International Journal of Obstetrics and Gynecology. 2018 Sep; 143(1): 20-7. doi: 10.1002/ijgo.12600. DOI: https://doi.org/10.1002/ijgo.12600

Averbach S, Kakaire O, Kayiga H. Immediate versus delayed postpartum use of levonorgestrel contraceptive implants: a randomized controlled trial in Uganda. American Journal of Obstetrics and Gynecology. 2017 Nov; 217(5): 568.e1-7. doi: 10.1016/j.ajog.2017.06.005. DOI: https://doi.org/10.1016/j.ajog.2017.06.005

Ahmed K, Baeten JM, Beksinska M, Bekker LG, Bukusi EA, Donnell D et al. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. The Lancet. 2019 Jul; 394(10195): 303-13.

Waldenström U, Cnattingius S, Vixner L, Norman M. Advanced maternal age increases the risk of very preterm birth, irrespective of parity: a population‐based register study. BJOG: An International Journal of Obstetrics & Gynaecology. 2017 Jul; 124(8): 1235-44. doi: 10.1111/1471-0528.14368. DOI: https://doi.org/10.1111/1471-0528.14368

Cutland CL, Lackritz EM, Mallett-Moore T, Bardají A, Chandrasekaran R, Lahariya C et al. Low birth weight: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine. 2017 Dec; 35(48): 6492. doi: 10.1016/j.vaccine.2017.01.049. DOI: https://doi.org/10.1016/j.vaccine.2017.01.049

Zhang Q, Dang S, Bai R, Mi B, Wang L, Yan H. Association between maternal interpregnancy interval after live birth or pregnancy termination and birth weight: a quantile regression analysis. Scientist Report. 2018 Mar; 8(1): 4130. doi: 10.1038/s41598-018-22498-0. DOI: https://doi.org/10.1038/s41598-018-22498-0

Schlaudecker EP, Munoz FM, Bardají A, Boghossian NS, Khalil A, Mousa H et al. Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Vaccine. 2017 Dec; 35(48): 6518. doi: 10.1016/j.vaccine.2017.01.040. DOI: https://doi.org/10.1016/j.vaccine.2017.01.040

Cyrkowicz A and Czekański A. Intrauterine growth retardation (IUGR) vs small for gestational age fetus (SGA). Diagnostic aspects. Ginekologia Polska. 1998 Apr; 69(4): 213-7.

Liauw J, Jacobsen GW, Larose TL, Hutcheon JA. Short interpregnancy interval and poor fetal growth: Evaluating the role of pregnancy intention. Paediatric and Perinatal Epidemiology. 2019 Jan; 33(1): O73-85. doi: 10.1111/ppe.12506. DOI: https://doi.org/10.1111/ppe.12506